As a wholly-owned subsidiary of Zhongyuan biotechnology holding group, Baofeng biology is mainly engaged in the R & D, production and sales of plant derived neurotrophic acid and related brain health products , is a global authoritative quasi Unicorn company providing integrated brain health solutions. With its leading technology, active market and social responsibility, the parent company has successfully listed on NASDAQ in the United States, and Baofeng biological is the technology of China And market representatives, will soon become the focus of brain health science and technology in the world!
Baofeng bio has a rare raw material resource, wild Acer truncatum original forest of nearly 300000 mu, which can effectively guarantee the yield and the content of nervonic acid in the products.
To build an international research and development platform for brain health, the expert team comes from clinical experts at home and abroad, doctor of biology of Chinese Academy of Sciences, master of pharmacy of Peking University, etc.
-
MISSION
Make outstanding healthy products with nervonic acid,
and make unremitting efforts for the brain health. -
VISION
Leading the development of the industry and becoming the
first brand in the field of brain health.
-
2012 Year Bao Feng Biotech was established with a registered capital of 10 million RMB.
2013 Year Construction of Acer Truncatum seedling & breeding base and promotion center in Wuqing District, Tianjin;
2014 Year Jointly launched by Beijing Forestry University and other units to establish the “China Woody Oil Industry Innovation Strategic Alliance”.2015: Bao Feng Biotech has 300,000 mu of Acer Truncatum original forest resources by cooperation with the Inner Mongolia Autonomous Region and the Liaoning Provincial Government.
-
2015 Year Bao Feng Biotech has 300,000 mu of Acer Truncatum original forest resources by cooperation with the Inner Mongolia Autonomous Region and the Liaoning Provincial Government.
2016 Year Establish R&D platform, doing nervonic acid purification and experiments, and developing a series of products;Start and prepare for overseas listing work.
2017 Year Obtained the national high-tech enterprise certification;Produce a series of capsule products which Cooperating with the Harvard R&D team of the United States.The Ministry of Health approved the use of nervonic acid as a new resource food.
-
2018 Year Nervonic acid products are produced in the United States and are FDA-approved and sold well both at china and abroad.
2019 Year Bao Feng Biotech will land on the NASDAQ market in the United States and become a public company; Continuous research and development of high-tech brain health products;Clinical cooperation with a number hospitals headed by Beijing Xuanwu Hospital;
-
Chen Xianyang, Ph.D.President of Baofeng biotechnology, Institute of Botany, Chinese Academy of Sciences, more than ten years of biological research and development experience. 17 SCI articles and 6 invention patents were published.
-
Dr. Christian Seth, Ph.D.Experts from the American Council of chemists, the American Society of clinical pathology, and the National Academy of Sciences Committee on clinical biochemistry.
-
Dr. Kurt Waller, MDDr. Kurt Waller has been engaged in preventive medicine research and clinical treatment. He has worked in Harvard University Massachusetts General Hospital, and is a research and neurodevelopmental expert in the Institute of chronic diseases.
-
Chauzy William, MD, Ph.D.Clinical chemotoxicologist and clinician. He was a senior researcher in endocrinology, nutrition, biochemistry, toxicology and immunology of the Centers for Disease Control and Prevention (CDC)
- International Certificate
- Domestic Certificate
